References
- SapolskyRMRomeroLMMunckAUHow do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actionsEndocr Rev2000211558910696570
- KadmielMCidlowskiJAGlucocorticoid receptor signaling in health and diseaseTrends Pharmacol Sci201334951853023953592
- RhenTCidlowskiJAAntiinflammatory aciton of glucocorticoids—New mechanisms for old drugsN Engl J Med2005353161711172316236742
- ColeTJBlendyJAMonaghanAPTargeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturationGenes Dev19959160816217628695
- BaschantUTuckermannJThe role of the glucocorticoid receptor in inflammation and immunityJ Steroid Biochem Mol Biol2010120697520346397
- MoraitisAGBlockTNguyenDBelanoffJKThe role of glucocorticoid receptors in metabolic syndrome and psychiatric illnessJ Steroid Biochem Mol Biol201716511412027002803
- JuddLLSchettlerPJBrownESAdverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effectsAm J Psychiatry2014171101045105225272344
- SchlossmacherGStevensAWhiteAGlucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cellsJ Endocrinol2011211172521602312
- HerrIUcurEHerzerKGlucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomasCancer Res200363311212012810637
- SchmidtSRainerJPlonerCPresulERimlSKoflerRGlucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevanceCell Death Differ200411S45S5515243581
- GasslerNZhangCWengerTDexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivoBr J Cancer2005921084108815756274
- PangDKocherginskyMKrauszTKimS-YConzenSDDexamethasone decreases xenograft response to paclitaxel through inhibition of tumor cell apoptosisCancer Biol Ther20065893394016775428
- ConzenSDNuclear receptors and breast cancerMol Endocrinol200822102215222818417735
- IsikbayMOttoKKregelSGlucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancerHormone Cancer2014527289
- ZhangCBeckermannBKallifatidisGCorticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastomaInt J Oncol2006291295130117016664
- SkorMNWonderELKocherginskyMGlucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancerClin Cancer Res201319226163617224016618
- Stringer-ReasorEMBakerGMSkorMNGlucocorticoid receptor activation inhibits chemotherapy-induced call death in high-grade serous ovarian carcinomaGynecol Oncol201513865666226115975
- GrossKLLuNZCidlowskiJAMolecular mechanisms regulating glucocorticoid sensitivity and resistanceMol Cell Endocrinol200930071619000736
- SmithLKCidlowskiJAGlucocorticoid-induced apoptosis of healthy and malignant lymphocytesProg Brain Res201018213020541659
- Gruver-YatesALCidlowskiJATissue-specific actions of glucocorticoids on apoptosis: a double-edged swordCells2013220222324709697
- PanDKocherginskyMConzenSDActivation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancerCancer Res201171206360637021868756
- NandaRChennamaneniPStringerEA randomized phase I trial of nanoparticle albumin bound paclitaxel (Agraxane) with or without mifepristone for advanced breast cancerSan Antonio Breast Cancer Symposium2013
- NandaRStringer-ReasorEMSahaPA randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancerSpringer Plus2016594727386391
- BakerGMMurphyTBlockTNguyenDLynchFJDevelopment and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancerCancer Manag Res2015736136826673410
- ClinicalTrials.govStudy identifiers: NCT02014337, NCT01493310, NCT02788981, and NCT02046421 Available from: https://clinicaltrials.gov/Accessed October 11, 2016
- AbduljabbarRNegmOHLaiC-FClinical and biological significance of glucocorticoid receptor (GR) expression in breast cancerBreast Cancer Res Treat201515033534625762479
- BuxantFEngohan-AlogheCNoelJ-CEstrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancerAppl Immunohistochem Mol Morphol20101825425719875955
- BelovaLDelgadoBKocherginskyMMelhemAOlopadeOIConzenSDGlucocorticoid receptor expression in breast cancer associates with older patient ageBreast Cancer Res Treat2009116444447
- ReedJAManahanLJParkC-SBrigatiDJComplete one-hour immunocytochemistry based on capillary actionBiotechniques19921334344431389176
- LienH-CLuY-SShunC-TYaoY-TChangW-CChengA-LDifferential expression of glucocorticoid receptor in carcinomas of the human digestive systemHistopathology20085231432418269582
- HammondMEHHayesDFDowsettMAmerican Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerArch Pathol Lab Med201013490792220524868
- WolffACHammondMEHHicksDGRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateArch Pathol Lab Med2014138224125624099077